1 research outputs found
Etiological spectrum and susceptibility to antibiotics of the leading bacterial causative agents of acute cholangitis
ΠΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΈΡΡ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄ ΠΊΡΠΌ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ°ΡΠ° ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ΡΠΎ Π½Π° Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½Π΅ΡΠΎ ΠΎΡΡΡΡ Ρ
ΠΎΠ»Π°Π½Π³ΠΈΡ ΠΈΠ·ΠΈΡΠΊΠ²Π° ΠΏΠΎΠ·Π½Π°Π²Π°Π½Π΅ Π½Π° ΡΠΏΠ΅ΠΊΡΡΡΠ° Π½Π° Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»Π½ΠΈΡΠ΅ ΠΏΡΠΈΡΠΈΠ½ΠΈΡΠ΅Π»ΠΈ ΠΈ ΡΡΡ
Π½Π°ΡΠ° ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»Π½ΠΎΡΡ ΠΊΡΠΌ Π°Π½ΡΠΈΠ±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»Π½ΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½ΠΈ ΡΡΠ΅Π΄ΡΡΠ²Π°. ΠΠ°ΡΡΠΎΡΡΠΎΡΠΎ ΠΏΡΠΎΡΡΠ²Π°Π½Π΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Ρ Π΄Π°Π½Π½ΠΈ Π·Π° Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»Π½ΠΈΡΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½ΠΈ, ΠΈΠ·ΠΎΠ»ΠΈΡΠ°Π½ΠΈ ΠΎΡ ΠΆΠ»ΡΡΠΊΠ° Π½Π° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ Ρ ΠΎΡΡΡΡ Ρ
ΠΎΠ»Π°Π½Π³ΠΈΡ (ΠΠ₯) ΠΈ ΡΡΡ
Π½Π°ΡΠ° Π°Π½ΡΠΈΠ±ΠΈΠΎΡΠΈΡΠ½Π° ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»Π½ΠΎΡΡ. ΠΠΎΠ΄Π΅ΡΠΈ ΠΏΡΠΈΡΠΈΠ½ΠΈΡΠ΅Π»ΠΈ Π½Π° Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½Π΅ΡΠΎ ΡΠ° Π³ΡΠ°ΠΌ-ΠΎΡΡΠΈΡΠ°ΡΠ΅Π»Π½ΠΈ Π±Π°ΠΊΡΠ΅ΡΠΈΠΈ - ΠΎΡΠ½ΠΎΠ²Π½ΠΎ E. coli, ΠΈΠ·ΠΎΠ»ΠΈΡΠ°Π½ΠΈ Π² 26.8% ΠΎΡ Π²ΡΠΈΡΠΊΠΈ ΠΈΠ·ΡΠ»Π΅Π΄Π²Π°Π½ΠΈ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»ΠΈ. Π‘ΡΠ΅Π΄ Π³ΡΠ°ΠΌ-ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»Π½ΠΈΡΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½ΠΈ Π½Π°ΠΉ-Π²ΠΈΡΠΎΠΊ Π΅ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»Π½ΠΈΡΡ Π΄ΡΠ» Π½Π° Π΅Π½ΡΠ΅ΡΠΎΠΊΠΎΠΊΠΈΡΠ΅ (E. feacalis ΠΈ E. faecium). ΠΠ°ΠΉ-Π²ΠΈΡΠΎΠΊΠ° Π΅ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΡΠ° Π½Π° ΠΈΠ·ΠΏΠΈΡΠ°Π½ΠΈΡΠ΅ Π±Π°ΠΊΡΠ΅ΡΠΈΠΈ ΠΊΡΠΌ Π°ΠΌΠΈΠ½ΠΎΠΏΠ΅Π½ΠΈΡΠΈΠ»ΠΈΠ½ΠΈ - 63.5%. ΠΠ°ΠΉ-Π²ΠΈΡΠΎΠΊΠ° in vitro Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡ Π΄Π΅ΠΌΠΎΠ½ΡΡΡΠΈΡΠ°Ρ imipenem, piperacillin / tazobactam, ciprofloxacin ΠΈ gentamicin Ρ Π½ΠΈΠ²Π° Π½Π° ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡ ΡΡΠΎΡΠ²Π΅ΡΠ½ΠΎ 2.8%, 14.8%, 14.6% ΠΈ 15.7%.The complex approach to the diagnosis and treatment of acute cholangitis requires knowledge about the spectrum of involved bacteria and their susceptibility to antibacterial drugs. The study provides information about bacterial pathogens, isolated from bile specimens of patients with acute cholangitis and their in vitro antibiotic susceptibility. The major causative agent of the disease are Gram-negative bacteria - mainly E. coli, presented in 26.8% of all tested samples. Among Gram-positive bacteria, the proportion of enterococci (E. feacalis and E. faecium) is the highest. The highest levels of resistance was detected for aminopenicillins - 63.5%. Imipenem, piperacillin/tazobactam, ciprofloxacin and gentamicin demonstrated the highest in vitro activity with resistance levels 2.8%, 14.8%, 14.6% and 15.7%, respectively